Bottom line
Is EIS a good fund? The bottom line
EIS is an index single country / region ETF from iShares.
Its expense ratio is 0.59% — about $59 a year on every $10,000 invested, cheaper than 72% of single country / region funds we track.
It returned +33.8% over one year, +7.2% a year over five years, +6.6% a year over ten (as of Dec 31, 2024, per its prospectus).
With $1.0 billion in net assets and 120 holdings, its largest position is Teva Pharmaceutical Industries Limited (8.8%) and the top 10 make up 51.7% of the portfolio.
What to watch
- Concentrated: top 10 holdings are 51.7% of assets
Updated Nov 19, 2026
What EIS invests in
The iShares MSCI Israel ETF (the Fund ) seeks to track the investment results of a broad-based index composed of Israeli equities.
The Fund seeks to track the investment results of the MSCI Israel Capped Investable Market Index (IMI) (the Underlying Index ), which is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Israel. The Underlying Index is rebalanced quarterly using an optimization process that aims to minimize the constituent weight differences between the Underlying Index and the MSCI Israel Index (the Parent Index ). The Underlying Index uses a capping methodology that limits the weight of any single group entity (constituents that MSCI determines have a control relationship) to a maximum of 25% of the Underlying Index weight, and the sum of all group entities with a weight above 5% to an aggregate of 50% of the Underlying Index weight. A group entity is a group of companies…
From the fund's prospectus (filed Dec 30, 2025).
EIS performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| EIS | +33.8% | +7.2% | +6.6% |
| Single Country / Region median | +21.5% | +4.1% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2024
What EIS costs
On a $10,000 investment, EIS's 0.59% expense ratio costs about $59 a year. The prospectus estimates $738 in total costs over 10 years (assuming 5% annual returns). The median single country / region fund charges 0.84%.
EIS top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Teva Pharmaceutical Industries Limited | 8.82% |
| 2 | Bank Leumi Le Israel B.m. | 8.17% |
| 3 | Bank Hapoalim B.m. | 6.98% |
| 4 | Tower Semiconductor Ltd | 6.95% |
| 5 | Elbit Systems Ltd | 5.52% |
| 6 | Nova Ltd | 3.36% |
| 7 | Phoenix Financial Ltd | 3.28% |
| 8 | Enlight Renewable Energy Ltd | 3.08% |
| 9 | Israel Discount Bank Limited | 2.95% |
| 10 | Mizrahi Tefahot Bank Ltd | 2.60% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 51.7% of the fund. See all top 25 holdings and asset mix →